Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy

Bevacizumab is thought to normalize tumor vasculature and restore the blood–brain barrier, decreasing enhancement and peritumoral edema. Conventional measurements of tumor response rely upon dimensions of enhancing tumor. After bevacizumab treatment, glioblastomas are more prone to progress as nonen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Whitney B., Young, Jonathan R., Ellingson, Benjamin M.
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075404/
https://www.ncbi.nlm.nih.gov/pubmed/21234719
http://dx.doi.org/10.1007/s11910-011-0179-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075404/
https://www.ncbi.nlm.nih.gov/pubmed/21234719
http://dx.doi.org/10.1007/s11910-011-0179-x

Ejemplares similares